JY-023

N/A

Report date: 2024/11/04 16:22:52

Base Information

Drug NameJY-023
Drug Alias NameJY-023
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Eastern Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Eastern Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A